Impact of neoadjuvant treatment on the accuracy of breast MRI and calliper in premenopausal ER-positive, HER2-negative, and node-positive breast cancer patients: Prospective phase III clinical trial

被引：0
|
作者：
Gwark, Sungchan
Ahn, Sei Hyun
Lee, Jong Won
Son, Byung Ho
Ko, Beom Seok
Kim, Jisun
Chung, Il-Yong
Lee, Sae Byul
Ahn, Jin-Hee
Jung, Kyung Hae
Kim, Sung-Bae
Lee, Hee Jin
Gong, Gyungyub
Kim, Hee Jeong
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P2-10-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-10-02
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Axillary Response to Neoadjuvant Therapy in Node-Positive ER-Positive, HER2-Negative Breast Cancer
    Friedman-Eldar, Orli
    Ozmen, Tolga
    Reyes, Fernando Valle
    Goel, Neha
    Tjendra, Youley
    Kesmodel, Susane B.
    Moller, Mecker
    Franceschi, Dido
    Avisar, Eli
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S236 - S236
  • [2] The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer
    Fjermeros, Kamilla
    Ghannoum, Salim
    Geisler, Stephanie B.
    Bhargava, Sameer
    Tahiri, Andliena
    Klajic, Jovana
    Luders, Torben
    Fongard, Marie
    Nawaz, Meh Sameen
    Bosnjak-Olsen, Tatjana
    Buvarp, Unn-Cathrin Edvardsen
    Johanna Rosenskiold, Aino Katri
    Nguyen, Nam Thi
    Sletbak, Tone Tysko
    Seyedzadeh, Manouchehr
    Selsas, Knut
    Porojnicu, Alina Carmen
    Skjerven, Helle Kristine
    Hovda, Tone
    Sahlberg, Kristine Kleivi
    Torland, Lilly Anne
    Lyngra, Marianne
    Hammarstrom, Clara Louise
    Honigsperger, Elma Bahonjic
    Noone, John Christopher
    Mathiassen, Silje
    Hurtado, Antoni
    Goel, Shom
    Koff, Andrew
    Tekpli, Xavier
    Kristensen, Vessela N.
    Geisler, Juergen
    FUTURE ONCOLOGY, 2024,
  • [3] Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer
    Matikas, Alexios
    Foukakis, Theodoros
    Michalakis, Ilias
    Georgoulias, Vassilis
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (04) : 319 - 326
  • [4] Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
    L S Rigter
    C E Loo
    S C Linn
    G S Sonke
    E van Werkhoven
    E H Lips
    H A Warnars
    P K Doll
    A Bruining
    I A Mandjes
    M J Vrancken Peeters
    J Wesseling
    K G Gilhuijs
    S Rodenhuis
    British Journal of Cancer, 2013, 109 : 2965 - 2972
  • [5] Neoadjuvant chemotherapy adaptation and serial MRI response monitoring in ER-positive HER2-negative breast cancer
    Rigter, L. S.
    Loo, C. E.
    Linn, S. C.
    Sonke, G. S.
    van Werkhoven, E.
    Lips, E. H.
    Warnars, H. A.
    Doll, P. K.
    Bruining, A.
    Mandjes, I. A.
    Peeters, M. J. Vrancken
    Wesseling, J.
    Gilhuijs, K. G.
    Rodenhuis, S.
    BRITISH JOURNAL OF CANCER, 2013, 109 (12) : 2965 - 2972
  • [6] Elacestrant for ER-Positive HER2-Negative Advanced Breast Cancer
    Hageman, Elizabeth
    Lussier, Mia E.
    ANNALS OF PHARMACOTHERAPY, 2024, 58 (08) : 849 - 856
  • [7] Elacestrant in advanced ER-positive, HER2-negative breast cancer
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (01) : 17 - 17
  • [8] The impact of intratumoral heterogeneity on the prognosis of ER-positive/HER2-negative breast cancer
    Oikawa, Masahiro
    Ishida, Mayumi
    Nakamura, Yoshiaki
    Nishimura, Sumiko
    Koga, Chinami
    Saruwatari, Akihiro
    Igawa, Akiko
    Akiyoshi, Sayuri
    Koi, Yumiko
    Ohno, Shinji
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Biomarkers of neoadjuvant/adjuvant endocrine therapy for ER-positive/HER2-negative breast cancer
    Ueno, Takayuki
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
  • [10] Survival is associated with complete response on MRI after neoadjuvant chemotherapy in ER-positive HER2-negative breast cancer
    Loo, Claudette E.
    Rigter, Lisanne S.
    Pengel, Kenneth E.
    Wesseling, Jelle
    Rodenhuis, Sjoerd
    Peeters, Marie-Jeanne T. F. D. Vrancken
    Sikorska, Karolina
    Gilhuijs, Kenneth G. A.
    BREAST CANCER RESEARCH, 2016, 18
12345